JP2010529468A5 - - Google Patents

Download PDF

Info

Publication number
JP2010529468A5
JP2010529468A5 JP2010511540A JP2010511540A JP2010529468A5 JP 2010529468 A5 JP2010529468 A5 JP 2010529468A5 JP 2010511540 A JP2010511540 A JP 2010511540A JP 2010511540 A JP2010511540 A JP 2010511540A JP 2010529468 A5 JP2010529468 A5 JP 2010529468A5
Authority
JP
Japan
Prior art keywords
individual
hbp
risk
determining whether
severe sepsis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2010511540A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010529468A (ja
JP5166522B2 (ja
Filing date
Publication date
Priority claimed from GBGB0711327.7A external-priority patent/GB0711327D0/en
Application filed filed Critical
Publication of JP2010529468A publication Critical patent/JP2010529468A/ja
Publication of JP2010529468A5 publication Critical patent/JP2010529468A5/ja
Application granted granted Critical
Publication of JP5166522B2 publication Critical patent/JP5166522B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2010511540A 2007-06-12 2008-06-12 診断方法 Active JP5166522B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0711327.7 2007-06-12
GBGB0711327.7A GB0711327D0 (en) 2007-06-12 2007-06-12 Diagnostic method
PCT/EP2008/004743 WO2008151808A1 (en) 2007-06-12 2008-06-12 Diagnostic method

Publications (3)

Publication Number Publication Date
JP2010529468A JP2010529468A (ja) 2010-08-26
JP2010529468A5 true JP2010529468A5 (enExample) 2011-07-28
JP5166522B2 JP5166522B2 (ja) 2013-03-21

Family

ID=38331957

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2010511540A Active JP5166522B2 (ja) 2007-06-12 2008-06-12 診断方法

Country Status (16)

Country Link
US (3) US8518648B2 (enExample)
EP (1) EP2129391B1 (enExample)
JP (1) JP5166522B2 (enExample)
KR (1) KR101563997B1 (enExample)
CN (2) CN103543271A (enExample)
AT (1) ATE548050T1 (enExample)
AU (1) AU2008261252B2 (enExample)
BR (1) BRPI0812875B8 (enExample)
CA (1) CA2690067C (enExample)
DK (1) DK2129391T3 (enExample)
ES (1) ES2380875T3 (enExample)
GB (1) GB0711327D0 (enExample)
PL (1) PL2129391T3 (enExample)
PT (1) PT2129391E (enExample)
SI (1) SI2129391T1 (enExample)
WO (1) WO2008151808A1 (enExample)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0711327D0 (en) 2007-06-12 2007-07-25 Hansa Medical Ab Diagnostic method
US20100240049A1 (en) 2009-01-16 2010-09-23 Cepheid Methods of Detecting Cervical Cancer
JP5488885B2 (ja) * 2009-10-28 2014-05-14 国立大学法人 東京大学 感染症の疾患マーカー
GB201016161D0 (en) * 2010-09-24 2010-11-10 Hansa Medical Ab Diagnostic method
AU2011334548B2 (en) * 2010-11-26 2016-06-09 Immunexpress Pty Ltd Diagnostic and/or screening agents and uses therefor
GB201102108D0 (en) * 2011-02-07 2011-03-23 Hansa Medical Ab Diagnostic method
AU2012308365A1 (en) * 2011-09-16 2014-04-24 Cepheid Methods of detecting sepsis
US10260111B1 (en) 2014-01-20 2019-04-16 Brett Eric Etchebarne Method of detecting sepsis-related microorganisms and detecting antibiotic-resistant sepsis-related microorganisms in a fluid sample
US10761093B2 (en) 2014-10-09 2020-09-01 Texas Tech University System Microdevice for cell separation utilizing activation phenotype
CN109541235A (zh) * 2018-08-19 2019-03-29 重庆早柒天生物科技股份有限公司 肝素结合蛋白和降钙素原二联检测试剂盒及其制备方法
US20220178932A1 (en) 2019-04-24 2022-06-09 Japanese Foundation For Cancer Research Cancer detection method and detection reagent
CN111208305B (zh) * 2020-02-16 2023-04-25 重庆翼锋生物科技有限公司 Hbp和pct在败血症诊断试剂制备中的用途
CN111951963B (zh) 2020-07-30 2022-09-02 中翰盛泰生物技术股份有限公司 Hbp在covid-19患者的预后风险预警中的应用
US20240230674A1 (en) * 2021-04-30 2024-07-11 Roche Diagnostics Operations, Inc. Strem1 marker panels for early detection of sepsis
JP2024516680A (ja) * 2021-04-30 2024-04-16 エフ． ホフマン－ラ ロシュ アーゲー 敗血症の早期検出用のｉｌ６マーカーパネル
EP4330685A2 (en) * 2021-04-30 2024-03-06 Roche Diagnostics GmbH Ngal marker panels for early detection of sepsis

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5627262A (en) 1989-07-05 1997-05-06 The Board Of Regents Of The University Of Oklahoma Method and composition for the treatment of septic shock
US5962241A (en) * 1989-07-28 1999-10-05 The University Of Arizona Monoclonal antibody detection of proteins on sperm related to fertility
US5314804A (en) * 1992-03-24 1994-05-24 Serim Research Corporation Test for Helicobacter pylori
HU221638B1 (hu) 1994-04-21 2002-12-28 Leukotech A/S Heparinkötő fehérje alkalmazása szepszis kezelésére szolgáló gyógyszer előállítására
US5976536A (en) 1995-08-09 1999-11-02 Emory University Neisseria mutants, lipooligosaccharides and immunogenic compositions
US5778895A (en) 1997-01-29 1998-07-14 Uab Research Foundation Method of discriminating bacterial from aseptic meningitis
US6303321B1 (en) * 1999-02-11 2001-10-16 North Shore-Long Island Jewish Research Institute Methods for diagnosing sepsis
US7655480B2 (en) 2002-03-08 2010-02-02 The Board Of Regents Of The University Of Oklahoma Method for predicting sepsis or an acute infectious inflammatory response
AU2003220034A1 (en) 2002-03-08 2003-09-22 Heloise, Anne, Pereira, Ph. D. An early detection marker for chronic inflammatory associated diseases
WO2004016653A2 (en) 2002-08-15 2004-02-26 Leukotech A/S Bactericidal, anti-apoptotic, pro-inflammatory and anti-inflammatory peptides of heparin-binding protein (hbp) or human neutrophil elastase
RU2005129745A (ru) * 2003-02-24 2006-03-20 Джитиси Байотерапьютикс, Инк. (Us) Способы и устройство проточной фильтрации вдоль потока
US7191068B2 (en) 2003-03-25 2007-03-13 Proteogenix, Inc. Proteomic analysis of biological fluids
WO2004112713A2 (en) 2003-06-20 2004-12-29 Royer Biomedical, Inc. Drug polymer complexes
WO2005028512A1 (en) 2003-09-19 2005-03-31 Leukotech A/S Pro-inflammatory and anti-inflammatory antibodies against the heparin-binding protein (hbp)
US20050196817A1 (en) 2004-01-20 2005-09-08 Molecular Staging Inc. Biomarkers for sepsis
JP2008538007A (ja) * 2005-04-15 2008-10-02 ベクトン，ディッキンソン アンド カンパニー 敗血症の診断
CA2624569A1 (en) 2005-10-03 2007-04-12 Biosite Incorporated Methods and compositions for diagnosis and/or prognosis in systemic inflammatory response syndromes
FR2894675B1 (fr) 2005-12-14 2008-06-27 Assist Publ Hopitaux De Paris Distinction des meningites bacteriennes et virales
GB0711327D0 (en) 2007-06-12 2007-07-25 Hansa Medical Ab Diagnostic method
GB201016161D0 (en) 2010-09-24 2010-11-10 Hansa Medical Ab Diagnostic method
GB201102108D0 (en) 2011-02-07 2011-03-23 Hansa Medical Ab Diagnostic method

Similar Documents

Publication Publication Date Title
De Backer et al. Microvascular blood flow is altered in patients with sepsis
Yeo et al. Impaired nitric oxide bioavailability and L-arginine–reversible endothelial dysfunction in adults with falciparum malaria
DeNotta et al. Clinical pathology in the adult sick horse: the gastrointestinal system and liver
Koenig et al. Usefulness of whole blood, plasma, peritoneal fluid, and peritoneal fluid supernatant glucose concentrations obtained by a veterinary point-of-care glucometer to identify septic peritonitis in dogs with peritoneal effusion
Davies Peritoneal solute transport and inflammation
Yaroustovsky et al. Selective polymyxin hemoperfusion in complex therapy of sepsis in children after cardiac surgery
JP2020519904A5 (enExample)
Govender et al. Extracorporeal circulation impairs microcirculation perfusion and organ function
Davis et al. Urinary neutrophil gelatinase‐associated lipocalin concentration changes after acute haemorrhage and colloid‐mediated reperfusion in anaesthetized dogs
Zhang et al. Intestinal mucosal permeability of children with cefaclor-associated serum sickness-like reactions
JP2013543581A5 (enExample)
Dhillon et al. Neutrophils, nitric oxide, and microvascular permeability in severe sepsis
Kashani et al. Association between kidney intracapsular pressure and ultrasound elastography
Chen et al. Free p-cresol sulfate is associated with survival and function of vascular access in chronic hemodialysis patients
Hahn Renal water conservation determines the increase in body weight after surgery: A randomized, controlled trial
Sikorska et al. Preliminary observations on the association between serum IL-6 and hydration status and cardiovascular risk in patients treated with peritoneal dialysis
Mandic et al. Body composition and inflammation in hemodialysis patients
Wang et al. Serum neutrophil gelatinase-associated lipocalin and proinflammatory cytokines in pigs with septic versus non-septic acute kidney injury
Ayoola et al. Association between endothelial dysfunction, biomarkers of renal function, and disease severity in sickle cell disease
CN106198953B (zh) 白介素-33在制备诊断肺源性急性肺损伤试剂盒中的用途
Pipili et al. Microcirculatory alterations during continuous renal replacement therapy in ICU: a novel view on the ‘dialysis trauma’concept
Derici et al. Does the urinary excretion of α1-microglobulin and albumin predict clinical disease activity in ulcerative colitis?
Khan Ideal biomarkers of acute kidney injury
CN105444862A (zh) 一种腹膜透析瘦体重检测装置
Guglani et al. Photoacoustic imaging assessment of acute kidney injury associated with experimental necrotizing enterocolitis